Press Release|Structured Credit

KBRA Assigns Ratings to Insurance Private Credit IV LLC

23 Dec 2025   |   New York

Contacts

KBRA assigns ratings to two classes of notes issued by Insurance Private Credit IV LLC (IPC IV), a direct lending facility that will originate and purchase middle market senior secured loans.

IPC IV is a maximum $892.5 million delayed draw middle market direct lending facility managed by Goldman Sachs Asset Management, L.P. (“GSAM L.P.” or the “collateral manager”). On the Conversion Date, which is expected to be the closing date of this amendment, a portion of the Subordinated Notes drawn will be converted at the direction of the collateral manager into a principal amount of Class A and B Notes, such that the total funded amount conforms to the Target Debt Ratio. Thereafter, the notes can be further drawn on a pro-rata basis up to the maximum commitment amounts to fund additional portfolio acquisitions of primarily middle market senior secured term loans to corporate borrowers.

The rated notes benefit from internal credit enhancement through subordination, overcollateralization, and excess spread. The collateral portfolio is comprised primarily of first-lien, senior secured middle market loans and has an initial K-WARF of 3064. The transaction has approximately 2.3 years remaining in the reinvestment period, during which the initial portfolio may experience turnover through trading and substitution. The portfolio may hold a limited amount of covenant-lite loans and first-lien last-out loans. The transaction will use a matrix based on weighted average spread (WAS) and weighted-average KBRA recovery rate (WARR) to maintain a minimum level of portfolio credit quality. The ratings reflect expected credit enhancement levels, excess spread, and coverage tests, including overcollateralization and interest coverage tests.

The rating on the Class A Notes considers the timely payment of interest and ultimate payment of principal by the applicable stated maturity date, while the rating on the Class B Notes consider the ultimate payment of interest and principal by the applicable stated maturity date.

To access ratings and relevant documents, click here.

Click here to view the report.

Methodologies

Disclosures

Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above.

A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here.

Information on the meaning of each rating category can be located here.

Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at www.kbra.com.

About KBRA

Kroll Bond Rating Agency, LLC (KBRA), one of the major credit rating agencies (CRA), is a full-service CRA registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a Designated Rating Organization (DRO) by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized as a Qualified Rating Agency by Taiwan’s Financial Supervisory Commission and is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider (CRP) in the U.S.

Doc ID: 1012727